Inventor
LIN SHI-LUNG
US27 patents
⚠️ This page may combine multiple inventors who share the name “LIN SHI-LUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIN SHI-LUNG
7 patentsUS9387251B2Jul 12, 2016
Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
LIN SHI-LUNG3 citations72
US8609831B2Dec 17, 2013
RNA-mediated gene modulation
LIN SHI-LUNG5 citations72
US9399773B2Jul 26, 2016
Production and extraction of MicroRNA precursor as drug for cancer therapy
LIN SHI-LUNG5 citations69
US9422559B2Aug 23, 2016
Production and utilization of a novel anti-cancer drug in therapy
LIN SHI-LUNG1 citations49
US9394538B2Jul 19, 2016
Development of universal cancer drugs and vaccines
LIN SHI-LUNG1 citations49
US9567591B2Feb 14, 2017
Generation of human embryonic stem-like cells using intronic RNA
LIN SHI-LUNG1 citations48
US9453219B2Sep 27, 2016
Cosmetic designs and products using intronic RNA
LIN SHI-LUNG1 citations46
LIN SHI LUNG
6 patentsUS12590329B2Mar 31, 2026
Replicase cycling reaction (RCR)
LIN SHI LUNG0 citations62
US11624067B2Apr 11, 2023
In-vitro induction of adult stem cell expansion and derivation
LIN SHI LUNG0 citations58
US9956196B2May 1, 2018
Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
LIN SHI LUNG0 citations48
US9907773B2Mar 6, 2018
Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
LIN SHI LUNG0 citations48
US10370658B2Aug 6, 2019
Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer
LIN SHI LUNG0 citations45
US12570977B2Mar 10, 2026
mRNA composition and production method for use in anti-viral and anti-cancer vaccines
LIN SHI LUNG0 citations40
MELLO BIOTECHNOLOGY INC
5 patentsUS9879263B2Jan 30, 2018
Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion
MELLO BIOTECHNOLOGY INC2 citations68
US9783811B2Oct 10, 2017
Inducible gene expression composition for using eukaryotic pol-2 promoter-driven transcription in prokaryotes and the applications thereof
MELLO BIOTECHNOLOGY INC1 citations50
US9637747B2May 2, 2017
Inducible gene expression composition for using eukaryotic pol-2 promoter-driven transcription in prokaryotes and the applications thereof
MELLO BIOTECHNOLOGY INC1 citations50
US10196662B2Feb 5, 2019
Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors
MELLO BIOTECHNOLOGY INC0 citations42
US10519440B2Dec 31, 2019
Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases
MELLO BIOTECHNOLOGY INC0 citations39
(unassigned)
4 patentsUS6197554B1Mar 6, 2001
Method for generating full-length cDNA library from single cells
163 citations96
US6130040AOct 10, 2000
Method for generating directly covalent bonding between interstrand nucleotides
6 citations62
US5928872AJul 27, 1999
Subtractive hybridization with covalently binding homology
6 citations61
US5871927AFeb 16, 1999
Nucleotide analog-containing hybrid subtraction with sequentially enzymatic digestion
3 citations61